US Stock MarketDetailed Quotes
LTRN Lantern Pharma
- 6.180
- -0.090-1.44%
Close May 28 16:00 ET
66.49MMarket Cap-3814P/E (TTM)
6.590High6.160Low90.11KVolume6.300Open6.270Pre Close570.26KTurnover1.14%Turnover RatioLossP/E (Static)10.76MShares11.99052wk High1.86P/B48.85MFloat Cap2.38052wk Low--Dividend TTM7.90MShs Float24.840Historical High--Div YieldTTM6.86%Amplitude2.380Historical Low6.328Avg Price1Lot Size
About Lantern Pharma Company
Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-100, LP-300, and LP-184. The company was founded by Arun K. Asaithambi, Gregory T. Tobin, and Peter L. Nara on November 7, 2013 and is headquartered in Dallas, TX.
Company Profile
SymbolLTRN
Company NameLantern Pharma
Listing DateJun 11, 2020
Issue Price15.00
Founded2013
CEOMr. Panna L. Sharma
MarketNASDAQ
Employees21
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1920 McKinney Avenue,7th floor
CityDallas
ProvinceTexas
CountryUnited States of America
Zip Code75201
Phone1-972-277-1136
Websitehttp://www.lanternpharma.com
Company Executives
- Name
- Position
- Salary
- Panna L. Sharma
- Chief Executive Officer, President and Director
- 684.39K
- David R. Margrave
- Principal Accounting Officer, Chief Financial Officer and Secretary
- 442.68K
- Dr. Kishor G. Bhatia, PhD
- Chief Scientific Officer
- 283.24K
- Donald Jeffrey Keyser
- Chairman of the Board
- 56.00K
- David S. Silberstein
- Director
- 46.00K
- Dr. Vijay Chandru
- Independent Director
- 46.00K
- Dr. Maria Maccecchini, PhD
- Independent Director
- 51.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg